Alizé Pharma presents clinical results from the AZP-531 program

Four projects supported by our foundation

AlizeePharma_3_actu

Alizé Pharma III raises €1.8 m in its first financing round

Alizé Pharma presents clinical results from the AZP-531 program

Published by Octalfa at 26 April 2015

Categories

AlizeePharma_actu

Date26 April 2015

The results from two Phase I clinical trials will be presented at the American Diabetes Association.